The COVID-19 pandemic is the largest public health challenge in living memory. Patients
with underlying liver disease have been disproportionately affected, experiencing high …

Abstract The coronavirus disease 2019 (COVID-19) pandemic is an ongoing global health
crisis causing major challenges for clinical care in patients with gastrointestinal diseases …

Background & Aims During the global coronavirus disease 2019 (COVID-19) pandemic,
patients with pre-existing chronic liver disease may represent a vulnerable population. We …

Aim Diabetes mellitus (DM) is a known risk factor for severe coronavirus disease 2019
(COVID‐19), but the clinical impact of undiagnosed diabetes and prediabetes in COVID‐19 …

Abstract Coronavirus disease 2019 (COVID-19) has several extrapulmonary symptoms.
Gastrointestinal (GI) symptoms are among the most frequent clinical manifestations of …

Liver pathology in COVID-19 related death and leading role of autopsy in the pandemic - PMC
Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI …

It is estimated that around 30% of the population living in Western countries has metabolic
dysfunction-associated steatotic liver disease (MASLD), a spectrum of pathology (not …

Introduction Coronavirus disease of 2019 (COVID-19) is a global health problem. The
impact of chronic liver diseases on the course and outcome of COVID-19 is still the subject …

Methods The methods used for this study have been described in detail elsewhere. 1, 2 The
National Vital Statistics System recently released quarterly provisional estimates to provide …

The SARS-CoV-2 pandemic raised many challenges for all patients with chronic conditions
and those with autoimmune diseases, both adults and children. Special attention is paid to …